277 related articles for article (PubMed ID: 1697668)
21. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
[TBL] [Abstract][Full Text] [Related]
22. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
23. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.
Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R
Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215
[TBL] [Abstract][Full Text] [Related]
24. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
[TBL] [Abstract][Full Text] [Related]
25. Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemia.
Perl A; Wang N; Williams JM; Hunt MJ; Rosenfeld SI; Condemi JJ; Packman CH; Abraham GN
J Immunol; 1987 Nov; 139(10):3512-20. PubMed ID: 3316385
[TBL] [Abstract][Full Text] [Related]
26. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
27. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
[TBL] [Abstract][Full Text] [Related]
28. Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14;18 translocation.
Amakawa R; Fukuhara S; Ohno H; Tanabe S; Horii M; Matsuyama F; Kato I; Kakita T; Nagauchi O
Cancer Res; 1990 Apr; 50(8):2423-8. PubMed ID: 2180570
[TBL] [Abstract][Full Text] [Related]
29. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
Mathieu-Mahul D; Bernheim A; Berger R; Mauchauffe M; Flandrin G; Larsen CJ
Nouv Rev Fr Hematol (1978); 1985; 27(3):157-61. PubMed ID: 2993997
[TBL] [Abstract][Full Text] [Related]
30. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining.
Haluska FG; Finver S; Tsujimoto Y; Croce CM
Nature; 1986 Nov 13-19; 324(6093):158-61. PubMed ID: 3097550
[TBL] [Abstract][Full Text] [Related]
31. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
32. Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.
Joos S; Haluska FG; Falk MH; Henglein B; Hameister H; Croce CM; Bornkamm GW
Cancer Res; 1992 Dec; 52(23):6547-52. PubMed ID: 1330296
[TBL] [Abstract][Full Text] [Related]
33. Establishment of the novel B acute lymphoblastic leukemia (FAB L3) cell line KHM-10B with a 13q34 abnormality and constitutive expression of c-myc and max during cell cycle.
Sonoki T; Matsuzaki H; Miyamoto K; Taniwaki M; Yoshino T; Hata H; Yoshida M; Matsuno F; Nagasaki A; Kuribayashi N
Leukemia; 1995 Dec; 9(12):2093-9. PubMed ID: 8609722
[TBL] [Abstract][Full Text] [Related]
34. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
35. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF; Griffin CA
Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
[TBL] [Abstract][Full Text] [Related]
36. A variant translocation places the lambda immunoglobulin genes 3' to the c-myc oncogene in Burkitt's lymphoma.
Hollis GF; Mitchell KF; Battey J; Potter H; Taub R; Lenoir GM; Leder P
Nature; 1984 Feb 23-29; 307(5953):752-5. PubMed ID: 6422306
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt.
Croce CM; Thierfelder W; Erikson J; Nishikura K; Finan J; Lenoir GM; Nowell PC
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6922-6. PubMed ID: 6417658
[TBL] [Abstract][Full Text] [Related]
38. A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and lambda light chain gene-carrying chromosomes.
Sugiyama H; Silva S; Babonits M; Potter M; Klein G; Wiener F
Cancer Genet Cytogenet; 1990 May; 46(1):93-7. PubMed ID: 2110029
[TBL] [Abstract][Full Text] [Related]
39. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
40. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
